158 related articles for article (PubMed ID: 23235175)
1. [A case of HER2-positive and AFP-producing gastric cancer successfully treated by trastuzumab/docetaxel/S-1 combination therapy].
Amano I; Sawai N; Mizuno C; Shaura Y; Nishiwaki M; Horimoto R; Oya H; Kato R; Seki K; Hashimoto H; Amakata Y; Matsumoto J; Tanaka I; Mizuno M; Shima T; Okanoue T
Gan To Kagaku Ryoho; 2012 Dec; 39(13):2541-4. PubMed ID: 23235175
[TBL] [Abstract][Full Text] [Related]
2. [A case of AFP-producing gastric cancer with peritoneal metastasis treated effectively with chemotherapy, mainly using S-1 and trastuzumab].
Nishiwada S; Watanabe A; Yoshikawa T; Ishioka K; Mukogawa T; Matsusaka M; Ko S; Ishikawa H
Gan To Kagaku Ryoho; 2013 Apr; 40(4):511-4. PubMed ID: 23848022
[TBL] [Abstract][Full Text] [Related]
3. [A case of SPT therapy( S-1+CDDP+trastuzumab) was successful for HER2-positive gastric cancer accompanied by distant lymph node metastasis].
Hyuga N; Kobayashi K; Watanabe R; Chono A; Matsumoto T; Takemoto H; Takachi K; Nishioka K; Aoki T; Uemura Y; Yoshida K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2256-8. PubMed ID: 24394077
[TBL] [Abstract][Full Text] [Related]
4. [Two cases of human epidermal growth factor receptor 2-positive advanced gastric cancer successfully treated with S-1, cisplatin, and trastuzumab combination therapy followed by curative resection].
Yasuyama A; Mikata S; Soma Y; Yoshikawa Y; Watase C; Kubota M; Miyake Y; Matsuura Y; Kim HM; Murakami M; Hirota M; Morishima H; Matsunami N; Hasegawa J; Miwa H; Nezu R
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2203-6. PubMed ID: 24394060
[TBL] [Abstract][Full Text] [Related]
5. A multi-institution phase II study of docetaxel and S-1 in combination with trastuzumab for HER2-positive advanced gastric cancer (DASH study).
Kagawa S; Muraoka A; Kambara T; Nakayama H; Hamano R; Tanaka N; Noma K; Tanakaya K; Kishimoto H; Shigeyasu K; Kuroda S; Kikuchi S; Kuwada K; Nishizaki M; Shirakawa Y; Fujiwara T
Cancer Chemother Pharmacol; 2018 Feb; 81(2):387-392. PubMed ID: 29290024
[TBL] [Abstract][Full Text] [Related]
6. [A case of AFP-producing gastric cancer resected after efficient S-1/CDDP combination chemotherapy].
Yoshioka M; Inoue N; Someda H; Noguchi M; Sawada M; Azuma K; Adachi A; Kuriyama D; Uose S; Nakamura T
Gan To Kagaku Ryoho; 2011 Jan; 38(1):105-8. PubMed ID: 21368468
[TBL] [Abstract][Full Text] [Related]
7. [A case of advanced HER2- positive gastric cancer with a partial response to molecular targeted chemotherapy (S-1+CDDP+Trastuzumab)].
Michiura T; Miyazaki S; Fujita S; Hirose H; Miyazaki Y; Sugimoto S; Yamabe K; Nagaoka M
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2346-8. PubMed ID: 25731518
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for alpha-fetoprotein producing gastric cancers expressing human epidermal growth factor receptor 2.
Hayashi K; Nagasaki E; Nakada K; Tamura M; Arakawa Y; Uwagawa T; Yano S
J Infect Chemother; 2018 Apr; 24(4):298-301. PubMed ID: 29174919
[TBL] [Abstract][Full Text] [Related]
9. [A case of unresectable HER2-positive advanced gastric cancer successfully treated by combination therapy with trastuzumab and paclitaxel].
Ojima E; Nishimura G; Nishijima K; Futagami F; Nakamura T; Hosokawa A
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2339-41. PubMed ID: 23268070
[TBL] [Abstract][Full Text] [Related]
10. [A case of gastric cancer that responded to a preoperative combination therapy of S-1/CDDP plus trastuzumab].
Sueoka S; Ito A; Kawanishi J; Sakakima Y
Gan To Kagaku Ryoho; 2014 Sep; 41(9):1155-7. PubMed ID: 25248902
[TBL] [Abstract][Full Text] [Related]
11. [Two cases of unresectable advanced gastric cancer treated with S-1, CDDP and trastuzumab].
Ogino T; Kawamura M; Tsutsumi K; Sakamoto N; Kodama H; Machida T; Takahashi T; Takanashi S; Nakamura Y; Ishii R
Gan To Kagaku Ryoho; 2013 Feb; 40(2):237-40. PubMed ID: 23411963
[TBL] [Abstract][Full Text] [Related]
12. [A Case in Which S-1/Oxaliplatin(SOX)/Trastuzumab Therapy Was Effective for Unresectable HER2 Positive Advanced Gastric Cancer and Radical Resection Could Be Performed].
Nagase H; Noguchi K; Hamabe A; Hirota M; Oshima K; Tanida T; Tomimaru Y; Kawase T; Morita S; Imamura H; Iwazawa T; Akagi K; Dono K
Gan To Kagaku Ryoho; 2017 Nov; 44(12):2000-2002. PubMed ID: 29394847
[TBL] [Abstract][Full Text] [Related]
13. [A Case of HER2-Positive Advanced Gastric Cancer with a Pathological Complete Response to Neoadjuvant Chemotherapy with S-1/CDDP/Trastuzumab].
Nishino M; Hosoda Y; Okano M; Nagai K; Yasui M; Kim Y; Tsujinaka T
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2043-5. PubMed ID: 26805258
[TBL] [Abstract][Full Text] [Related]
14. A phase II prospective study of the trastuzumab combined with 5-weekly S-1 and CDDP therapy for HER2-positive advanced gastric cancer.
Kataoka H; Mori Y; Shimura T; Nishie H; Natsume M; Mochizuki H; Hirata Y; Sobue S; Mizushima T; Sano H; Mizuno Y; Nakamura M; Hirano A; Tsuchida K; Adachi K; Seno K; Kitagawa M; Kawai T; Joh T
Cancer Chemother Pharmacol; 2016 May; 77(5):957-62. PubMed ID: 27002325
[TBL] [Abstract][Full Text] [Related]
15. Trastuzumab combined with docetaxel-based regimens in previously treated metastatic gastric cancer patients with HER2 over-expression.
Dai GH; Shi Y; Chen L; Lv YL; Zhong M
Hepatogastroenterology; 2012; 59(120):2439-44. PubMed ID: 22534547
[TBL] [Abstract][Full Text] [Related]
16. [Two cases of advanced gastric cancer with peritoneal dissemination, and Virchow's metastases successfully treated by combination therapy of S-1 and docetaxel].
Kubo H; Kijima T; Kitahara M; Tada K; Miyahara M; Hasegawa H
Gan To Kagaku Ryoho; 2010 Jan; 37(1):147-50. PubMed ID: 20087051
[TBL] [Abstract][Full Text] [Related]
17. [A case of advanced gastric cancer successfully treated by combination therapy of S-1 and docetaxel].
Sato T; Oshima T; Yamamoto N; Fukahori M; Makino H; Nagano Y; Fujii S; Rino Y; Masuda M; Imada T; Kunisaki C
Gan To Kagaku Ryoho; 2009 Sep; 36(9):1541-4. PubMed ID: 19755829
[TBL] [Abstract][Full Text] [Related]
18. Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study.
Thuss-Patience PC; Shah MA; Ohtsu A; Van Cutsem E; Ajani JA; Castro H; Mansoor W; Chung HC; Bodoky G; Shitara K; Phillips GDL; van der Horst T; Harle-Yge ML; Althaus BL; Kang YK
Lancet Oncol; 2017 May; 18(5):640-653. PubMed ID: 28343975
[TBL] [Abstract][Full Text] [Related]
19. [HER2-Positive Advanced Gastric Cancer with Disseminated Intravascular Coagulation and Diffuse Bone Marrow Carcinomatosis Successfully Treated with S-1/Trastuzumab Chemotherapy--A Case Report].
Senoo S; Mannami T; Tamura T; Fujiwara N; Ikeda G; Komoda M; Ohtawa Y; Fujimoto Y; Sato N; Kambara T; Waku T; Kenmotsu M; Kurimoto E; Okada T; Harita S; Sonobe H
Gan To Kagaku Ryoho; 2015 Dec; 42(13):2471-5. PubMed ID: 26809307
[TBL] [Abstract][Full Text] [Related]
20. Trastuzumab in combination with docetaxel/cisplatin/S-1 (DCS) for patients with HER2-positive metastatic gastric cancer: feasibility and preliminary efficacy.
Mitsui Y; Sato Y; Miyamoto H; Fujino Y; Takaoka T; Miyoshi J; Kagawa M; Ohnuma H; Hirakawa M; Kubo T; Osuga T; Sagawa T; Sato Y; Takahashi Y; Katsuki S; Okuda T; Takimoto R; Kobune M; Nobuoka T; Hirata K; Kato J; Takayama T
Cancer Chemother Pharmacol; 2015 Aug; 76(2):375-82. PubMed ID: 26099968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
